Educational Disclaimer: This case study is for educational and informational purposes only. It does not constitute medical advice, clinical guidance, or a substitute for professional psychiatric evaluation. All diagnostic criteria referenced are from the DSM-5-TR (APA, 2022). Clinical statistics cited are drawn from peer-reviewed literature and may vary across populations. Clinicians should rely on their professional training, direct patient assessment, and current evidence-based guidelines when making diagnostic and treatment decisions.

Clinical Vignette

Patient: "Mr. T," 22-year-old male college student, brought to the emergency department by his roommate who reports that Mr. T has been "acting paranoid" for the past 3 weeks.

Chief Complaint (roommate): "He thinks people are following him. He won't leave his room and he talks to himself at night."

History of Present Illness: Mr. T reports hearing voices commenting on his behavior over the past 3 weeks. The voices are experienced as external and distinct from his own thoughts. He endorses paranoid ideation: he believes his professors are monitoring his internet activity and that classmates are "in on it." He has been isolating in his dorm room, missing classes for 2 weeks. Appetite has decreased. Sleep is reduced to 3-4 hours/night due to hypervigilance. Hygiene has declined.

Substance Use: Mr. T reports daily cannabis use (high-potency concentrates via vape pen) for the past 8 months. He escalated from occasional flower cannabis to daily concentrate use when his roommate introduced him to vaping. He reports his last use was 5 days ago. He also reports occasional alcohol use. Denies stimulant, hallucinogen, or other substance use. Urine toxicology is positive for THC.

Premorbid Functioning: Mr. T maintained a 3.4 GPA through his first two years of college. Friends describe him as outgoing and social prior to the past 6 months. Over the past 6 months, he has become increasingly withdrawn and suspicious, has dropped from 15 to 9 credit hours, and has had difficulty maintaining friendships.

Family History: Paternal uncle has schizophrenia (diagnosed at age 24). No other known psychiatric family history.

Medical History: No significant medical history. No head trauma. No seizure history.

Mental Status Exam: Disheveled appearance. Poor eye contact. Psychomotor retardation. Speech low volume, increased latency. Thought process loosely associated. Thought content significant for auditory hallucinations (running commentary), paranoid delusions (persecutory), and ideas of reference. Denies suicidal ideation. Denies homicidal ideation. Insight absent; judgment impaired.

Step 1: Medical Etiology Exclusion

DSM-5-TR mandates exclusion of medical conditions before diagnosing a primary psychotic disorder. In a 22-year-old presenting with first-episode psychosis, the essential medical workup includes:

  • Complete metabolic panel — rule out metabolic encephalopathy
  • Thyroid function — hyperthyroidism can produce psychotic symptoms
  • Complete blood count — infection screening
  • Urinalysis — rule out UTI (especially relevant in elderly but included in standard workup)
  • Urine toxicology screen — completed; positive for THC
  • Head CT or MRI — rule out space-occupying lesion, especially with first-episode presentation
  • RPR/VDRL — rule out neurosyphilis
  • HIV testing — HIV-associated neurocognitive disorder can present with psychosis

For this analysis, we assume all medical workup returns within normal limits. If abnormalities are found, the diagnostic formulation must be reevaluated.

Step 2: Substance-Induced Psychotic Disorder (SIPD) Evaluation

This is the critical first question in the hierarchical exclusion: Are the psychotic symptoms caused by cannabis?

DSM-5-TR Criteria for SIPD

Criterion A: Prominent hallucinations or delusions.

Mr. T has auditory hallucinations (running commentary) and persecutory delusions. MET.

Criterion B: Evidence from history, physical examination, or laboratory findings that symptoms developed during or soon after substance intoxication or withdrawal, AND the substance is capable of producing the symptoms.

Evidence For SIPD: Cannabis (especially high-potency THC concentrates) is established as capable of inducing psychotic symptoms. Mr. T escalated to daily high-potency concentrate use 8 months ago. Symptoms emerged during active daily use.

Evidence Against SIPD: Symptoms have persisted for 3 weeks, with the most recent cannabis use 5 days ago. Classic cannabis-induced psychosis typically resolves within days to 1-2 weeks of abstinence. Persistence beyond this window increases the probability of a primary psychotic disorder.

Timeline Analysis

8 months ago

Began daily high-potency cannabis concentrate use

6 months ago

Social withdrawal begins. Reduced credit hours. "Increasingly suspicious." This predates the acute psychotic symptoms and may represent a prodromal phase.

3 weeks ago

Onset of auditory hallucinations and paranoid delusions

5 days ago

Last cannabis use

Present

Symptoms persist 5 days after cessation. Auditory hallucinations, paranoid delusions, and social withdrawal continue.

Critical Diagnostic Ambiguity

This case sits in a diagnostic gray zone. Cannabis can act as (1) a direct cause of psychosis (SIPD), (2) a trigger that precipitates a primary psychotic disorder in a genetically vulnerable individual, or (3) a confound in a patient who was already developing a primary psychotic disorder independently. The 6-month prodromal period of social withdrawal and suspiciousness before the onset of frank psychosis complicates the substance-causation model. Research demonstrates that daily high-potency cannabis use increases the risk of first-episode psychosis by substantially, particularly in individuals with family history of psychotic disorders.

Step 3: Schizophrenia Evaluation

Criterion A: Two or more of the following, each present for a significant portion of time during a 1-month period. At least one must be (1), (2), or (3).

  1. Delusions — Persecutory delusions (professors monitoring him, classmates conspiring). Ideas of reference. MET.
  2. Hallucinations — Auditory hallucinations with running commentary, experienced as external. MET.
  3. Disorganized speech — "Loosely associated" thought process on MSE. MET.
  4. Grossly disorganized or catatonic behavior — Hygiene decline, isolation, functional deterioration. Partially present but does not reach the threshold of grossly disorganized behavior. Possibly met.
  5. Negative symptoms — Flat affect (not explicitly stated but suggested by psychomotor retardation), avolition (missing classes, social withdrawal), alogia (low-volume speech with increased latency). MET.

Three of five symptoms clearly met (delusions, hallucinations, disorganized speech), with negative symptoms also present. Criterion A is MET.

Criterion B: Level of functioning markedly below that achieved prior to onset.

GPA decline (3.4 to failing), reduced credit load (15 to 9), social withdrawal, loss of friendships, self-care deterioration. MET.

Criterion C: Continuous signs of disturbance for at least 6 months, including at least 1 month of Criterion A symptoms.

The prodromal period of social withdrawal and suspiciousness began approximately 6 months ago. Active psychotic symptoms (Criterion A) have been present for 3 weeks (nearly 1 month). If symptoms persist through the 1-month mark, this criterion is met. The 6-month total duration criterion is met by including the prodromal phase. Nearly MET; requires observation.

Criterion E: The disturbance is not attributable to the physiological effects of a substance.

This is the central diagnostic dilemma. The concurrence of heavy cannabis use and psychotic symptom onset prevents definitive determination. CANNOT be fully satisfied at this time.

Step 4: Brief Psychotic Disorder Consideration

If symptoms resolve within 1 month and SIPD is ruled out, Brief Psychotic Disorder (BPD) should be considered. Key features:

  • Duration of at least 1 day but less than 1 month
  • Full return to premorbid functioning
  • Current symptom duration (3 weeks) is within the BPD window
  • However, the 6-month prodromal phase and negative symptoms are atypical for BPD and favor a more chronic process

Diagnostic Formulation

Working Diagnosis

Unspecified Schizophrenia Spectrum and Other Psychotic Disorder (F29)

This provisional diagnosis appropriately reflects the diagnostic uncertainty. The clinical presentation is most consistent with early schizophrenia (age of onset, family history, prodromal period, negative symptoms, Criterion A symptoms) but the co-occurring cannabis use prevents definitive exclusion of SIPD (Criterion E).

Recommended Next Steps

  1. Ensure sustained abstinence from cannabis and all substances. Repeat urine toxicology in 2-3 weeks to confirm clearance.
  2. Initiate antipsychotic medication regardless of the final etiological determination. First-episode psychosis warrants treatment (typically a second-generation antipsychotic at the lowest effective dose).
  3. Monitor symptom trajectory during abstinence. If psychotic symptoms fully resolve within 1 month of sustained abstinence, SIPD becomes the likely diagnosis. If symptoms persist beyond 1 month of abstinence, a primary psychotic disorder is confirmed.
  4. Reassess at 6 months for full Criterion C evaluation (schizophrenia vs. schizophreniform disorder).
  5. Obtain detailed premorbid history from parents regarding childhood social development, academic performance, and any subclinical oddities that might represent early schizoid or schizotypal traits.
  6. Psychoeducation with family regarding the diagnosis, treatment expectations, and the critical importance of cannabis abstinence given the interaction between THC and psychosis vulnerability.

Teaching Points

  • The DSM-5-TR hierarchical exclusion process requires ruling out substance and medical etiologies before diagnosing a primary psychotic disorder. In first-episode psychosis with concurrent substance use, a period of observed abstinence (typically 1 month) is often necessary to clarify the diagnosis.
  • High-potency cannabis (concentrates with high THC concentrations) carries significantly higher psychosis risk than traditional flower cannabis (lower THC concentrations). This dose-response relationship is well-established in epidemiological data.
  • Cannabis-induced psychosis and schizophrenia are distinct diagnostic entities but share a complex relationship. A significant proportion of individuals with cannabis-induced psychosis convert to a primary psychotic disorder within subsequent years. First-degree family history of schizophrenia increases this conversion rate.
  • The presence of negative symptoms (avolition, alogia, flat affect) favors a primary psychotic disorder over SIPD. Substance-induced presentations typically feature prominent positive symptoms (hallucinations, delusions) with less pronounced negative symptomatology.
  • A 6-month prodromal period of subtle functional decline preceding frank psychosis is characteristic of schizophrenia and is rarely observed in SIPD.
  • Treatment should not be withheld pending diagnostic clarification. Duration of untreated psychosis (DUP) correlates inversely with treatment response and long-term functional outcomes.